Compositional changes in fecal microbiota associated with clinical phenotypes and prognosis in Korean patients with inflammatory bowel disease/Experiment 1

From BugSigDB


Reviewed Marked as Reviewed by Peace Sandy on 2024-1-26

Curated date: 2023/11/24

Curator: Yjung24

Revision editor(s): Yjung24, Peace Sandy

Subjects

Location of subjects
South Korea
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Ulcerative colitis colitis ulcerative,Colitis, Ulcerative,Left-sided ulcerative (chronic) colitis,Left-sided ulcerative colitis,left-sided ulcerative colitis,Other ulcerative colitis,Other ulcerative colitis (disorder),UC - ulcerative colitis,ulcerative colitis,ulcerative colitis (disease),ulcerative colitis (disorder),Ulcerative colitis, unspecified,ULCERATVE COLITIS UNSPCF,Ulcerative colitis
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy control individual
Group 1 name Corresponds to the case (exposed) group for case-control studies
Ulcerative colitis patient
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients diagnosed with ulcerative colitis from 3 different academic hospitals in Korea.
Group 0 sample size Number of subjects in the control (unexposed) group
100
Group 1 sample size Number of subjects in the case (exposed) group
70
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
Patients who used drugs can affect intestinal microbial community, such as probiotics and antibiotics, within a month were excluded.

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
3.0

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
decreased
Chao1 Abundance-based estimator of species richness
decreased

Signature 1

Reviewed Marked as Reviewed by Peace Sandy on 2024-1-26

Curated date: 2023/11/24

Curator: Yjung24

Revision editor(s): Yjung24, Atrayees

Source: Figure 4a

Description: Taxa list according to linear discriminate analysis values determined from comparisons between HC and UC patients. HC, healthy control individuals; UC, ulcerative colitis.

Abundance in Group 1: increased abundance in Ulcerative colitis patient

NCBI Quality ControlLinks
Bifidobacterium dentium
Blautia obeum
Enterocloster clostridioformis
Flavonifractor plautii
Haemophilus parainfluenzae
Lachnospira eligens
Proteus vulgaris
Veillonella dispar
Parabacteroides

Revision editor(s): Yjung24, Atrayees

Signature 2

Reviewed Marked as Reviewed by Peace Sandy on 2024-1-26

Curated date: 2023/11/24

Curator: Yjung24

Revision editor(s): Yjung24

Source: Figure 4a

Description: Taxa list according to linear discriminate analysis values determined from comparisons between HC and UC patients. HC, healthy control individuals; UC, ulcerative colitis.

Abundance in Group 1: decreased abundance in Ulcerative colitis patient

NCBI Quality ControlLinks
Megamonas rupellensis
Alistipes putredinis
Bifidobacterium pseudolongum
Ruminococcus bromii
Dorea longicatena
Parabacteroides merdae
Bifidobacterium pullorum subsp. gallinarum
Collinsella aerofaciens
Holdemanella biformis
Subdoligranulum variabile
Mediterraneibacter faecis
Ligilactobacillus ruminis
Senegalimassilia anaerobia
Akkermansia muciniphila

Revision editor(s): Yjung24